Michel Janier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michel Janier has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Nicolas Dupin
Dermatology Department Cochin Hospital Paris France
25 shared publications Section Mst De La Sfd
20 shared publicationsCh Derancourt
10 shared publicationsB Halioua
7 shared publicationsS Verraes-Derancourt
7 shared publications- Brigitte Milpied
Reference center for toxic bullous dermatoses and severe drug reactions TOXIBUL Créteil France
6 shared publications
Latest Publications
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 710-712
Gonococcie
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 710-712
Gonococcie
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 765-766
Orchiépididymite
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 765-766
Orchiépididymite
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 720-724
Syphilis précoce
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 720-724
Syphilis précoce
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 770-772
Balanite
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 770-772
Balanite
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 701-702
Recommandations diagnostiques et thérapeutiques pour les maladies sexuellement transmissibles
- 1 November 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 701-702
Recommandations diagnostiques et thérapeutiques pour les maladies sexuellement transmissibles
- 20 October 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 767-769
MST anorectales
- 20 October 2016
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 143 (11) , 767-769
MST anorectales
- 15 September 2015
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 30 (10) , e78-e79
2014 European guideline on the management of syphilis: giving evidence priority
- 15 September 2015
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 30 (10) , e78-e79
2014 European guideline on the management of syphilis: giving evidence priority
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 5, 459-475
2014 European guideline on the management of syphilis
Reprinted and translated from Journal of the European Academy of Dermatology and Venereology 28 (2014) “2014 European guideline on the management of syphilis” pp. 1581-1593, Copyright 2014 with permission © 2014 European Academy of Dermatology and Venereology. Background. Syphilis...
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 5, 459-475
2014 European guideline on the management of syphilis
Reprinted and translated from Journal of the European Academy of Dermatology and Venereology 28 (2014) “2014 European guideline on the management of syphilis” pp. 1581-1593, Copyright 2014 with permission © 2014 European Academy of Dermatology and Venereology. Background. Syphilis...
- Top Cited Papers
- 27 October 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (12) , 1581-1593
2014 European guideline on the management of syphilis
Background: Syphilis remains a major public health problem in Europe (both in Eastern Europe since the 1990's and in Western Europe since the re‐emergence of the disease in the late 1990's‐early 2000's).Methods: This guideline is an update of the IUSTI: 2008 European guideline on the management of syphilis and is produced by the European Guideline Editorial Board (http://www.iusti.org/regions/Europe/pdf/2013/Editorial_Board.pdf) and EDF Guideline Committee.Results: It provides recommendations concerning the diagnosis and management of syphilis in Europe. Major advances include (1) broader use of PCR, immunohistochemistry, subtyping of the etiological agent Treponema pallidum subspecies pallidum, new treponemal tests, and rapid‐point‐of‐care (POC) tests detecting both treponemal and non‐treponemal antibodies, (2) more flexible options for screening (TT‐treponemal test‐ first or NTT –non treponemal test‐ first or both TT and NTT), and (3) procaine penicillin is no longer the first line therapy option in any phase of the disease, i.e. long acting penicillin G (i.e. benzathine penicillin G‐BPG) is the only first line therapy regimen in early syphilis and in late latent syphilis.Conclusions: Syphilis is a disease that is relatively easy to detect by appropriate serological tests, however, all laboratory results should be considered together with clinical data and sexual risk anamnesis. Syphilis is also easy to treat with BPG. A major concern about the supply of BPG in many European countries could threaten the efficacy of the policies of eradication of the disease in Europe.
- 27 October 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (12) , 1581-1593
Top Cited Papers2014 European guideline on the management of syphilis
Background: Syphilis remains a major public health problem in Europe (both in Eastern Europe since the 1990's and in Western Europe since the re‐emergence of the disease in the late 1990's‐early 2000's).Methods: This guideline is an update of the IUSTI: 2008 European guideline on the management of syphilis and is produced by the European Guideline Editorial Board (http://www.iusti.org/regions/Europe/pdf/2013/Editorial_Board.pdf) and EDF Guideline Committee.Results: It provides recommendations concerning the diagnosis and management of syphilis in Europe. Major advances include (1) broader use of PCR, immunohistochemistry, subtyping of the etiological agent Treponema pallidum subspecies pallidum, new treponemal tests, and rapid‐point‐of‐care (POC) tests detecting both treponemal and non‐treponemal antibodies, (2) more flexible options for screening (TT‐treponemal test‐ first or NTT –non treponemal test‐ first or both TT and NTT), and (3) procaine penicillin is no longer the first line therapy option in any phase of the disease, i.e. long acting penicillin G (i.e. benzathine penicillin G‐BPG) is the only first line therapy regimen in early syphilis and in late latent syphilis.Conclusions: Syphilis is a disease that is relatively easy to detect by appropriate serological tests, however, all laboratory results should be considered together with clinical data and sexual risk anamnesis. Syphilis is also easy to treat with BPG. A major concern about the supply of BPG in many European countries could threaten the efficacy of the policies of eradication of the disease in Europe.
- 27 June 2014
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 25 (13) , 901-912
2014 European Guideline on the management of sexually acquired reactive arthritis
- 27 June 2014
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 25 (13) , 901-912
2014 European Guideline on the management of sexually acquired reactive arthritis